Twitter Facebook
news.png

The Driven Researcher

eBook Summary of Vaccines Textbook

Posted by Claire Dwoskin on Oct 12, 2015 1:48:00 PM

New eBook Summarizes Studies in the First Medical Textbook Linking Vaccines and Autoimmunity

Despite blanket assurances in the media that all vaccines are entirely and indisputably safe, the subject of vaccine-related illnesses continues to be studied rigorously by respected medical institutions around the world.  Why?  Because the rising rates of chronic disease in general and automimmune disease specifically makes it imperative that we understand the effects of ALL medications we put into our bodies and our children’s.

So, while current vaccine manufacturers and many former ones now in decision-making positions at the Centers for Disease Control have focused on the short-term effects of vaccines, there remains a troubling lack of studies on their long-term effects and the ingredients used to create them.

Funding independent research and providing the results of peer-reviewed studies to the public is CMSRI’s mission and the impetus behind our funding of the recently released medical textbook, Vaccines and Autoimmunity, edited by Yehuda Shoenfeld, MD, FRCP, Nancy Agmon-Levin, MD and Lucija Tomljenovic , PhD.   

This is the first medical textbook to examine the role of adjuvants in different vaccines and how they can induce diverse autoimmune clinical manifestations in genetically prone individuals.  It is comprised of a compilation of studies by clinical physicians and scientists at major universities and research hospitals in the United States, Canada, United Kingdom, Israel, Japan, Sweden, France, Italy, Spain, Greece, Brazil, Columbia, Mexico and Slovenia.

As a dense and highly technical medical textbook, it is a bit unwieldy for the average concerned parent or individual (and it costs $159). That’s why we’ve created a free eBook, A Summary of Studies in Vaccines and Autoimmunity, containing the key conclusions from this landmark text.  

Vaccines and Autoimmunity

 

 

 

 

It's Time for a Closer Look at Long-Term Vaccine Safety

Adjuvants, which are added ingredients that stimulate an immune response, are at the center of these studies. Currently, aluminum is by far the most common adjuvant and researchers are concerned about its long-term effects. Most studies agree that aluminum adjuvants have some influence on autoimmune disease in certain patients and the big question is whether adjuvants cause disease or exacerbate existing conditions. 

Among the conclusions included in this “Summary of Studies” eBook are:

  • Vaccines in patients with autoimmune inflammatory rheumatic diseases indicate that those patients are at increased risk for infection following some vaccinations.
  • Given that the death rate from cervical cancer in 9 to 20-year-old girls is zero, the short-term risks from the HPV vaccine to otherwise healthy individuals seems to significantly outweigh the as-yet-unproven long-term benefits of the vaccine.
  • Data supports the relationship between the H1N1 vaccine in the development of narcolepsy under certain conditions.
  • Certain predisposed patients are at increased risk for neurological autoimmune disorders following the hepatitis B vaccine. The most common connection, so far, is between the hepatitis B vaccine and multiple sclerosis (MS)

One pressing message is echoed throughout the studies:  Vaccines are an essential part of preventative modern medicine, but the potential for them to trigger the autoimmune/ inflammatory syndrome induced by adjuvants (ASIA) should not be ignored.  

The Children’s Medical Safety Research Institute (CMSRI) is a medical and scientific collaborative established to provide research funding for independent studies on causal factors underlying the chronic disease and disability epidemic.
  

Subscribe to The Driven Researcher

Immunization Journal Download
Vaccines and Autoimmunity

Breaking News

The Driven Researcher Posts


The Foundation is a registered 501(c)(3) non-profit organization. Your contribution is tax deductible to the full extent allowed by law.
100% of your donations funds NEW CMSRI research